Angiotensin signaling and apoptosis in the neonatal heart: necessary evils?
Bishopric
Nanette H
NH
Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, PO Box 016189 (R-189), Miami, FL 33101, USA. n.bishopric@miami.edu
D000328:Adult; D000804:Angiotensin II / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D017209:Apoptosis / Q000502:physiology*; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000502:physiology; D006321:Heart / Q000187:drug effects / Q000254:growth & development*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007231:Infant, Newborn; D032383:Myocytes, Cardiac / Q000166:cytology / Q000502:physiology*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011945:Receptors, Angiotensin / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin; D000804:Angiotensin II